argenx SE 2021 Annual Report with Sustainability Disclosures
Company: argenx SE
Sector: Manufacturing
Country: Netherlands
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 167
The report describes argenx's transition to a fully integrated immunology company following the first approval of VYVGART in 2021. The company expanded to 650 employees and reported total revenue of 497,277 USD thousands, driven mainly by collaboration and milestone payments. It also crossed the 500-employee threshold for the first time and provided its first disclosures under the EU Non-Financial Reporting Directive and EU Taxonomy requirements.
Services
From bulk PDFs to structured indicators and machine-readable documents.